STOCK TITAN

BD to Present at the BofA Securities 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BD (Becton, Dickinson and Company) will present at the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 12:00 p.m. Pacific Time. Investors can access the live webcast from BD's investor relations website, with a replay available post-event. BD, a leading global medical technology firm, is dedicated to advancing health through innovative technology and solutions, supporting healthcare providers and improving patient outcomes. BD boasts a workforce of 75,000 and operates globally to address significant health challenges.

Positive
  • None.
Negative
  • None.

FRANKLIN LAKES, N.J., April 29, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 12:00 p.m. Pacific Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:




Media:

Investors:

Troy Kirkpatrick

Francesca DeMartino

VP, Public Relations

SVP, Investor Relations

858.617.2361

201.847.5743       

troy.kirkpatrick@bd.com

francesca.demartino@bd.com    

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-present-at-the-bofa-securities-2022-healthcare-conference-301536530.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When is BD presenting at the BofA Securities 2022 Healthcare Conference?

BD will present on May 11, 2022, at 12:00 p.m. Pacific Time.

How can I access BD's presentation at the Healthcare Conference?

The presentation can be accessed via the BD investor relations website.

Is there a replay available for BD's presentation?

Yes, a replay will be available on the BD investor relations website after the event.

What is BD's focus in the medical technology sector?

BD focuses on improving medical discovery, diagnostics, and care delivery.

What is BD's stock symbol?

BD's stock symbol is BDX.

Becton, Dickinson and Co.

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Stock Data

65.62B
288.35M
0.28%
91.75%
0.73%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
FRANKLIN LAKES